L-Carnitine
| Category | Compounds |
|---|---|
| Also known as | Levocarnitine, 3-Hydroxy-4-N-trimethylaminobutyrate, Carnitor, L-3-Hydroxytrimethylaminobutanoate |
| Last updated | 2026-04-14 |
| Reading time | 4 min read |
| Tags | quaternary-ammoniumfatty-acid-oxidationmitochondrialmetabolicamino-acid-derivative |
Overview
L-Carnitine is a quaternary ammonium compound derived from the amino acids lysine and methionine. It is not a peptide — technically a trimethylated amino acid derivative — but is frequently included in peptide research catalogs because it shares physiological space with metabolic peptides such as FGF21, adiponectin, and irisin, and is widely used in mitochondrial and fat-metabolism research.
L-Carnitine's essential role is the transport of long-chain fatty acids (14+ carbons) across the inner mitochondrial membrane, where they undergo beta-oxidation to generate acetyl-CoA and ultimately ATP. Without the carnitine shuttle, long-chain fatty acids cannot enter the mitochondrial matrix, and fat oxidation capacity is severely impaired.
The compound is available both as an endogenous metabolite (synthesized in liver and kidney) and as a dietary component (predominantly from red meat and dairy). It is an approved pharmaceutical for primary carnitine deficiency (under the generic name levocarnitine) and is widely available as a supplement and research chemical.
Structure / Chemistry
- IUPAC name: (R)-3-hydroxy-4-(trimethylammonio)butanoate
- Molecular formula: C7H15NO3
- Molecular weight: 161.2 g/mol
- Stereochemistry: L (R) form is the biologically active enantiomer; D-carnitine is inactive and may be inhibitory
- Common derivatives: Acetyl-L-carnitine (ALCAR), propionyl-L-carnitine
The molecule carries a permanent positive charge on its quaternary ammonium group and a carboxylate at the opposite end, producing a zwitterion at physiological pH. Its hydroxyl and carboxyl groups allow acylation, generating acylcarnitines that are the actual transported species in the carnitine shuttle.
Mechanism of Action
L-Carnitine operates through the carnitine shuttle system:
- Carnitine palmitoyltransferase 1 (CPT1) on the outer mitochondrial membrane transfers long-chain fatty acyl groups from CoA to carnitine, forming long-chain acylcarnitines
- Carnitine-acylcarnitine translocase (CACT) in the inner membrane exchanges acylcarnitine for free carnitine
- Carnitine palmitoyltransferase 2 (CPT2) on the matrix side regenerates acyl-CoA for beta-oxidation, releasing free carnitine
- Buffering of mitochondrial acetyl-CoA by acetylcarnitine formation modulates the acetyl-CoA/CoA ratio
- Antioxidant and membrane-stabilizing effects reported in various cell culture studies
Beyond fatty acid transport, L-carnitine has been studied for vascular endothelial effects, sperm motility support, and cognitive effects (particularly acetyl-L-carnitine).
Research Summary
| Study / Year | Model | Key Finding |
|---|---|---|
| Stanley et al., 1991 | Primary carnitine deficiency | Established levocarnitine as standard therapy for OCTN2-deficient patients |
| Lango et al., 2001 | Ischemic heart disease | Meta-analysis indicated small improvements in exercise tolerance |
| DiNicolantonio et al., 2013 | Post-MI patients | Meta-analysis suggested reduced all-cause mortality with L-carnitine |
| Wall et al., 2011 | Healthy men | Chronic L-carnitine + carbohydrate increased muscle carnitine content and altered fuel use |
| Malaguarnera et al., 2007 | Hepatic encephalopathy | L-carnitine improved cognitive parameters vs placebo |
Pharmacokinetics
Oral L-carnitine has limited bioavailability (approximately 15% for pharmacologic doses), with much of an oral dose fermented by gut microbiota to trimethylamine and ultimately TMAO. IV carnitine achieves high plasma concentrations but also rapid renal clearance.
Plasma half-life is approximately 15 hours following IV dosing and longer after oral dosing due to slow absorption. Tissue uptake, particularly into skeletal muscle, is mediated by the OCTN2 transporter and is rate-limiting; achieving elevated muscle carnitine content requires sustained high plasma levels in the presence of insulin, which stimulates OCTN2 activity. Elimination is primarily renal, with extensive tubular reabsorption.
Common Discussion Topics
- Technical distinction: carnitine is an amino acid derivative, not a peptide
- Acetyl-L-carnitine vs L-carnitine vs propionyl-L-carnitine in different research contexts
- TMAO production from oral carnitine and cardiovascular debate
- Insulin dependence of skeletal muscle carnitine uptake
- Role in primary and secondary carnitine deficiency states
Related Compounds
- Carnosine — dipeptide with overlapping metabolic research interest
- Glutathione — tripeptide antioxidant, commonly catalogued alongside
- AICAR — AMPK activator with metabolic overlap
- FGF21 — metabolic hormone relevant to fatty acid oxidation
- Adiponectin — adipokine modulating insulin sensitivity and fat oxidation
Educational information only. L-Carnitine is available as a prescription medicine (levocarnitine) and as a dietary supplement. This article does not constitute medical or dosing advice.
Sourcing research-grade compounds
Obtaining high-purity, research-grade L-Carnitine requires verified and trusted suppliers with third-party COA testing and transparent sourcing practices.
White Market Peptides — Verified Supplier →Join the discussion
See how the community is discussing L-Carnitine. Share your experience, ask questions, and explore protocols on PepAtlas.
Related entries
- AICAR— A cell-permeable nucleotide analog that activates AMP-activated protein kinase, widely used as a research tool in metabolism and endurance studies.
- Carnosine— A naturally occurring dipeptide (beta-alanyl-L-histidine) concentrated in skeletal muscle and brain tissue, studied for its antioxidant, pH buffering, anti-glycation, and potential anti-aging properties.
- Glutathione— A ubiquitous tripeptide (gamma-Glu-Cys-Gly) serving as the principal intracellular antioxidant and the central molecule in phase II detoxification, with widespread supplementation and clinical interest in oxidative stress conditions.